You are here

Merck

Pfizer, Merck launch large new trials of oral COVID-19 drugs

BioPharma Dive

Wed, 09/1/21 - 01:30 pm

clinical trials

Merck's Keytruda survives FDA scrutiny in bladder cancer, but ends up with a smaller label

Fierce Pharma

Wed, 09/1/21 - 01:26 pm

Merck, Amgen adopt double-digit price hikes in test to Big Pharma's unofficial annual limits: analyst

Fierce Pharma

Wed, 09/1/21 - 11:23 am

The sellside’s most controversial products

EP Vantage

Tue, 08/31/21 - 10:54 am

Vir Biotechnology

Merck's 15-strain flu shot matches Prevnar 13 in late-stage infant study, but Pfizer's next-gen shot looms

Endpoints

Wed, 08/25/21 - 11:16 am

clinical trials

FDA Action Alert: Cara/Vifor, Kadmon, BMS, Merck/Eisai

BioSpace

Mon, 08/23/21 - 11:10 am

Cara Therapeutics

Bristol Myers Squibb

Organon Makes Women’s Health a Priority

Pharmaforum

Fri, 08/20/21 - 10:55 am

GSK's Jemperli follows Merck's Keytruda with FDA nod to target certain tumors regardless of location

Fierce Pharma

Wed, 08/18/21 - 11:08 am

Organon shares jump as Merck's new women's health spinoff posts strong start for biosims, infertility drugs

Fierce Pharma

Mon, 08/16/21 - 10:51 pm

Merck joins its peers with plan to cut access to discounted drugs for contract pharmacies

Endpoints

Mon, 08/16/21 - 10:18 pm

contract pharmacies

Merck kicks off oral COVID-19 antiviral filing in Canada

Pharmaforum

Mon, 08/16/21 - 11:04 am

Merck's Welireg scores FDA nod in cancers spurred by rare disease—and its label is broader than expected

Fierce Pharma

Sat, 08/14/21 - 01:44 pm

Peloton Therapeutics

von Hippel-Lindau disease

Merck's Best Seller Keytruda Racks Up Another Regulatory Win

BioSpace

Thu, 08/12/21 - 12:35 pm

advanced renal cell carcinoma

renal cell carcinoma

FDA says it needs a little more time to decide on Merck's P2X3 for chronic cough

Endpoints

Thu, 08/12/21 - 11:12 am

FDA starts speedy review of Keytruda for adjuvant kidney cancer

Pharmaforum

Wed, 08/11/21 - 10:57 am

Biotech M&A tracker: After hitting new heights, deals have slowed down. Here are the latest.

BioPharma Dive

Tue, 08/10/21 - 11:12 pm

Xeris Pharmaceuticals

Relay Therapeutics

Beam Therapeutics

Jazz Pharmaceuticals

Merck's Vaxneuvance lead departs to help develop rival vaccine at Affinivax

Fierce Biotech

Mon, 08/9/21 - 12:12 pm

Merck's Keytruda takes home adjuvant win in melanoma, escalating early-line fight with Bristol Myers

Endpoints

Thu, 08/5/21 - 11:05 am

clinical trials

Chasing Merck & Co, Bayer builds case for cough drug eliapixant

Pharmaforum

Wed, 08/4/21 - 10:49 am

clinical trials

Can Merck Beat Pfizer in This Multibillion-Dollar Vaccine Market?

Motley Fool

Sun, 08/1/21 - 11:50 pm

pneumococcal disease

Pages